ADVERTISEMENT
-
Publications
-
Meetings
-
Education
-
About
-
Resources
Advertisement
ADVERTISEMENT
StimLabs announced enrollment of the first patient in the CAMPSTIM multi-center RCT that aims to demonstrate the clinical outcomes of at least four of StimLabs' placental-based tissue products with standard of care (SOC) vs SOC alone in patients with hard-to-heal DFUs.
Advertisement
Advertisement
Advertisement